Opinion|Videos|September 30, 2024
Factors to Consider When Switching Therapies
The discussion covers when to consider transitioning to a new therapeutic option in CLL and the factors that influence the decision between dose modification and switching therapies.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- When is transitioning to a new therapeutic option considered, and what factors influence the decision between dose modification and switching therapies in chronic lymphocytic leukemia treatment?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
World Schizophrenia Day: One Pharmacist's Vision for Safer Schizophrenia Care
2
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
3
Early Oral Antiviral Use Associated With Lower Risk of Post–COVID-19 Condition, Study Finds
4
The CGM Data Point Pharmacists Should Always Check First
5